J VIRAL HEPATITIS:中国农村近两百万备孕夫妇乙肝流行率现状

2017-04-24 MedSci MedSci原创

乙型肝炎病毒(HBV)感染是导致全球高死亡率和社会负担的主要健康问题。全球估计有20亿人感染HBV,其中2.46亿人为慢性感染,发生肝功能失代偿、肝硬化和肝细胞癌的风险增加。更为重要的是,中国的HBV感染负担居世界之最,估计有7460万HBsAg携带者。尽管过去二十年间,中国从HBV高流行率降至中度流行率,但HBV感染人群的绝对数量仍然非常大。尽管成功实施了婴幼儿普遍乙型肝炎疫苗接种计划,中国一直

近日,来自北京大学儿童公共卫生学院青少年和妇女的健康研究院的研究人员报道了一项关于我国农村备孕夫妇的HBsAg/HBeAg流行率的观察性研究,相关研究成果刊登于国际杂志J VIRAL HEPATITIS上。

目前对于备孕夫妇HBV感染患病率的研究很少。研究人员评估了在中国农村备孕夫妇中乙型肝炎表面抗原(HBsAg)和乙型肝炎e抗原(HBeAg)的流行程度,以及HBV流行率与配偶中HBsAg / HBeAgALT状态之间的关系。

乙型肝炎病毒(HBV感染是导致全球高死亡率和社会负担的主要健康问题。全球估计有20亿人感染HBV,其中2.46亿人为慢性感染,发生肝功能失代偿、肝硬化和肝细胞癌的风险增加。更为重要的是,中国的HBV感染负担居世界之最,估计有7460HBsAg携带者。尽管过去二十年间,中国从HBV高流行率降至中度流行率,但HBV感染人群的绝对数量仍然非常大。尽管成功实施了婴幼儿普遍乙型肝炎疫苗接种计划,中国一直面临新的挑战。

研究人员进行了全国范围的横断面研究,使用2010年至2012年间31个省备孕的1 936 801名农村夫妇的健康检查计划数据。ELISA用于检测血清学样本,研究人员定义了HBsAg不一致或两者都是阳性的(PC)。在1 936 801对夫妇中,202 816人(10.47; 95CI10.43-10.51%)为PC。检测到202 816HBsAg阳性对的56 474例(27.84; 95CI27.65-28.04%)HBeAg(高感染性)。多变量模型显示,在调整潜在的混杂因素后,妻子中HBV感染的流行率随着其丈夫的HBsAg / HBeAg和丙氨酸氨基转移酶(ALT)的阳性状态增加(调整后的比值从2.31增加到4.98)。同样地,丈夫中HBV感染的流行与HBsAg / HBeAg和其妻子的ALT呈正相关(调整后的优势比从2.04增加到4.93)。

研究结果表明,在中国农村准备怀孕的夫妇中,男性患病率高,HBV感染患病率与配偶HBsAg / HBeAgALT的阳性状态独立相关。孕妇怀孕前不要仅仅关注母亲,而应该将阳性夫妇当作重要的护理单位。

原始出处:

J. Liu,Yan D,Liu M.et al.Prevalence of HBsAg/HBeAg among 1 936 801 couples preparing for pregnancy in rural China: An bservational study.JVH.27 March 2017.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1720729, encodeId=ede61e207296e, content=<a href='/topic/show?id=a7ff65385f1' target=_blank style='color:#2F92EE;'>#流行率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65385, encryptionId=a7ff65385f1, topicName=流行率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44c32960238, createdName=lixiaol, createdTime=Sun Aug 13 07:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404996, encodeId=d95f140499670, content=<a href='/topic/show?id=2c4a30e76c7' target=_blank style='color:#2F92EE;'>#农村#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30776, encryptionId=2c4a30e76c7, topicName=农村)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b76a2518787, createdName=daviiliu, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426719, encodeId=55c51426e19c2, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436710, encodeId=ecce1436e10e2, content=<a href='/topic/show?id=9166424e48b' target=_blank style='color:#2F92EE;'>#备孕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42474, encryptionId=9166424e48b, topicName=备孕)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464149, encodeId=78711464149b2, content=<a href='/topic/show?id=21298689f6' target=_blank style='color:#2F92EE;'>#hepatitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8689, encryptionId=21298689f6, topicName=hepatitis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30066593077, createdName=zhishijing, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=)]
    2017-08-13 lixiaol
  2. [GetPortalCommentsPageByObjectIdResponse(id=1720729, encodeId=ede61e207296e, content=<a href='/topic/show?id=a7ff65385f1' target=_blank style='color:#2F92EE;'>#流行率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65385, encryptionId=a7ff65385f1, topicName=流行率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44c32960238, createdName=lixiaol, createdTime=Sun Aug 13 07:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404996, encodeId=d95f140499670, content=<a href='/topic/show?id=2c4a30e76c7' target=_blank style='color:#2F92EE;'>#农村#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30776, encryptionId=2c4a30e76c7, topicName=农村)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b76a2518787, createdName=daviiliu, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426719, encodeId=55c51426e19c2, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436710, encodeId=ecce1436e10e2, content=<a href='/topic/show?id=9166424e48b' target=_blank style='color:#2F92EE;'>#备孕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42474, encryptionId=9166424e48b, topicName=备孕)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464149, encodeId=78711464149b2, content=<a href='/topic/show?id=21298689f6' target=_blank style='color:#2F92EE;'>#hepatitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8689, encryptionId=21298689f6, topicName=hepatitis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30066593077, createdName=zhishijing, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=)]
    2017-04-25 daviiliu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1720729, encodeId=ede61e207296e, content=<a href='/topic/show?id=a7ff65385f1' target=_blank style='color:#2F92EE;'>#流行率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65385, encryptionId=a7ff65385f1, topicName=流行率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44c32960238, createdName=lixiaol, createdTime=Sun Aug 13 07:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404996, encodeId=d95f140499670, content=<a href='/topic/show?id=2c4a30e76c7' target=_blank style='color:#2F92EE;'>#农村#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30776, encryptionId=2c4a30e76c7, topicName=农村)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b76a2518787, createdName=daviiliu, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426719, encodeId=55c51426e19c2, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436710, encodeId=ecce1436e10e2, content=<a href='/topic/show?id=9166424e48b' target=_blank style='color:#2F92EE;'>#备孕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42474, encryptionId=9166424e48b, topicName=备孕)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464149, encodeId=78711464149b2, content=<a href='/topic/show?id=21298689f6' target=_blank style='color:#2F92EE;'>#hepatitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8689, encryptionId=21298689f6, topicName=hepatitis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30066593077, createdName=zhishijing, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=)]
    2017-04-25 gwc384
  4. [GetPortalCommentsPageByObjectIdResponse(id=1720729, encodeId=ede61e207296e, content=<a href='/topic/show?id=a7ff65385f1' target=_blank style='color:#2F92EE;'>#流行率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65385, encryptionId=a7ff65385f1, topicName=流行率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44c32960238, createdName=lixiaol, createdTime=Sun Aug 13 07:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404996, encodeId=d95f140499670, content=<a href='/topic/show?id=2c4a30e76c7' target=_blank style='color:#2F92EE;'>#农村#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30776, encryptionId=2c4a30e76c7, topicName=农村)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b76a2518787, createdName=daviiliu, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426719, encodeId=55c51426e19c2, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436710, encodeId=ecce1436e10e2, content=<a href='/topic/show?id=9166424e48b' target=_blank style='color:#2F92EE;'>#备孕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42474, encryptionId=9166424e48b, topicName=备孕)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464149, encodeId=78711464149b2, content=<a href='/topic/show?id=21298689f6' target=_blank style='color:#2F92EE;'>#hepatitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8689, encryptionId=21298689f6, topicName=hepatitis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30066593077, createdName=zhishijing, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=)]
    2017-04-25 zhouqu_8
  5. [GetPortalCommentsPageByObjectIdResponse(id=1720729, encodeId=ede61e207296e, content=<a href='/topic/show?id=a7ff65385f1' target=_blank style='color:#2F92EE;'>#流行率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65385, encryptionId=a7ff65385f1, topicName=流行率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44c32960238, createdName=lixiaol, createdTime=Sun Aug 13 07:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404996, encodeId=d95f140499670, content=<a href='/topic/show?id=2c4a30e76c7' target=_blank style='color:#2F92EE;'>#农村#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30776, encryptionId=2c4a30e76c7, topicName=农村)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b76a2518787, createdName=daviiliu, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426719, encodeId=55c51426e19c2, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436710, encodeId=ecce1436e10e2, content=<a href='/topic/show?id=9166424e48b' target=_blank style='color:#2F92EE;'>#备孕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42474, encryptionId=9166424e48b, topicName=备孕)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464149, encodeId=78711464149b2, content=<a href='/topic/show?id=21298689f6' target=_blank style='color:#2F92EE;'>#hepatitis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8689, encryptionId=21298689f6, topicName=hepatitis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30066593077, createdName=zhishijing, createdTime=Tue Apr 25 15:00:00 CST 2017, time=2017-04-25, status=1, ipAttribution=)]

相关资讯

Hepatology:袁正宏教授发现宿主限制乙肝病毒复制及cccDNA表观调控的机制

日前,肝病学领域国际学术期刊《Hepatology》在线发表了复旦大学上海医学院基础医学院教育部/卫计委医学分子病毒学重点实验室袁正宏课题组联合上海市公共卫生临床中心科研人员题为“PRMT5 Restricts Hepatitis B Virus Replication via Epigenetic Repression of cccDNA Transcription and Interferen

中国艾滋乙肝合并感染分布图绘出

北京协和医院感染内科李太生教授团队绘制出中国艾滋病病毒—乙肝病毒共感染地区分布图,揭示出乙肝能加速艾滋病发展进程,合并感染不影响抗艾药物疗效和肝毒性,并探索出效优价廉的艾滋病病毒—乙肝共感染治疗新策略。围绕该项课题,团队已发表论文14篇,其中SCI论文10篇。研究结果被我国艾滋病诊疗指南引用;诊疗方案在广西、云南等艾滋病防治示范区推广应用,显着提高了治疗成功率。艾滋病和乙肝有相同感染途径,其他国家

乙肝患者生孩子 需要注意这些细节

现代医学关于乙肝母婴传播的阻断做的已经相当不错了,只要女性乙肝患者可以主意好这些细节,生一个健康宝宝并不是遥不可及的梦想。

Hepatology:乙肝治疗前后肝纤维化评估新分类

背景:纤维生成和纤维溶解动态变化的最终结果是肝脏纤维化。证据表明抗病毒治疗可逆转肝脏纤维化,甚或是HBV导致的早期肝硬化。然而,近期的评估系统主要关注纤维化的严重程度,而非其动态变化。方法:我们提出一种评估纤维化动态变化的新的分类:显着进展(厚/宽/疏松/分隔模糊伴炎症);显着逆转(着色浅/窄/致密/分隔)和表现为改善和退化瘢痕形成总体平衡的中间状态。然后,我们使用该分类评估恩替卡韦治疗前和治疗后

Hepatology:乙肝肝移植术后恩替卡韦单药治疗长期预后

背景:慢性乙型肝炎(CHB)的患者肝移植后,长期抗病毒治疗对预防乙肝复发是必须的。方法:我们观察265例未使用乙肝免疫球蛋白(HBIG)恩替卡韦单一药物治疗的乙型肝炎(CHB)肝移植患者的长期预后。期间定期进行病毒血清学、病毒载量和肝脏生化指标检测。结果:中位随访时间为59个月。累积乙型肝炎表面抗原(HBsAg)血清学清除率在1年和5年时分别为90%和95%。1、3、5、8年HBsAg阴性率分别为

Sci Rep:血清HBcrAg是乙肝HBV-DNA的一种新型标志物!

最近,有一些建议认为乙型肝炎核心相关抗原(HBcrAg)可以作为乙型肝炎病毒(HBV)感染的另一种标记物。近期,一项发表在杂志Sci Rep上的研究旨在探讨血清定量HBcrAg(qHBcrAg)是否为肝内共价闭合环状DNA(cccDNA)的一种替代标志物。此项研究共有139名患者进行肝活检,包括59名免疫耐受(IT)阶段患者,52名免疫清除(IC)阶段患者,18名低复制(LR)阶段患者以及10名重